In evaluating point mutations in breast cancer, Qu et al. achieved a high Area Under the Curve (AUC) in predicting point mutations in TP53, RB1, CDH1, NF1 and NOTCH2 and copy number alterations (CNA) in 6 additional genes64. The gene discussed is TP53; the disease is breast carcinoma.